SANTA MONICA, Calif.,
Feb. 14, 2013 /PRNewswire/ -- Leading pharmaceutical business and marketing publication
Med Ad News
Appature, the leading software-as-a-service (SaaS) provider for life science marketers, are excited to continue the
Med Ad News Webinar Series: Enabling the New Marketing Model, sponsored by Appature. This series addresses how Marketing teams and Commercial Operations are building the capabilities needed for a new, more complex era of data-driven marketing.
The second episode in the series,
How to Leverage Technology, Automation and Data to Deliver a High Touch Strategy ,
Wednesday, March 20, 2013 at
12:00 p.m. ET (
11:00 p.m. CT,
9:00 a.m. PT), brings together three experts from different domains – relationship marketing strategy, commercial operations, and marketing technology – to outline the key steps needed to build scalable, personalized and high touch marketing programs. Attendees will learn how to apply automation to manage the customer experience, use data to plan and optimize campaigns, and identify gaps in the organization's current marketing technology capabilities to mitigate competitive threats and ensure effective performance in 2013 and beyond.
Episode 2: How to Leverage Technology, Automation and Data to Deliver a High Touch Strategy
This Webcast will feature presentations by
, Senior Director of Marketing Services and Commercial Projects, Shire;
, President, DKI Healthcare Relationship Marketing; and
, Vice President of Marketing, Appature. The Webcast concludes with a live Q&A session moderated by
, Director of Content,
Med Ad News
and UBM Canon, Pharmaceuticals
This episode of the series will take place on
Wednesday, March 20, 2013
12:00 p.m. ET
11:00 p.m. CT
9:00 a.m. PT
). The webinar will be archived for one year on the
. Register only once, and have access to the webinar series, real-time chat and twitter feeds, and a library of information and resources. For more information or to register for the event, please
Dates for the remaining 2013 webinars have been announced:
Episode 3: Gaining Strategic Advantage Through a 360 Customer View –
June 12, 2013
Episode 4: Optimizing Channel Integration And Customer Experience –
September 11, 2013
Episode 5: Achieving Organizational Agility In Data-Driven Marketing -
December 11, 2013
For more information or to register for the event, please
About Med Ad News
The pharmaceutical industry's publication of record for 30 years,
Med Ad News
provides broad coverage and incisive analysis of the issues, events, trends, and strategies shaping pharmaceutical business, marketing, and sales. More than 16,500 readers – comprising corporate executives, marketing, sales, and product managers – receive
Med Ad News
12 times per year.
Med Ad News
is a publication of UBM Canon Pharmaceutical Media Group. More info visit
About Appature, Inc.
Appature, Inc. is a Seattle‐based technology company that provides a "surprisingly simple" cloud‐based
software platform, Appature Nexus, designed exclusively for healthcare and life science companies. Appature Nexus enables marketers to deepen brand relationships and drive share growth with a platform that integrates the marketing database, campaign management tool and analytics suite into one easy‐to‐use tool. Leaders in the pharmaceutical, medical device and consumer healthcare industries rely on Appature to realize the full potential of their customer relationships. Please visit
About UBM Canon
UBM Canon, the leading B-to-B media company dedicated exclusively to the global
advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and
development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of
(UBM.L) a global provider of media and information services for professional B2B communities and markets.
SOURCE Med Ad News; UBM Canon
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts